A selective 5-HT1a receptor agonist improves respiration in a mouse model of Rett syndrome

Journal of Applied Physiology

Volumn 115, Issue 11, 2013, Pages 1626-1633

  Levitt, Erica S ^a   Hunnicutt, Barbara J ^a   Knopp, Sharon J ^b   Williams, John T ^a   Bissonnette, John M ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Apnea; Rett syndrome; Serotonin

Indexed keywords

3 CHLORO 4 FLUOROPHENYL (4 FLUORO 4 (((5 METHYLPYRIMIDIN 2 YLMETHYL)AMINO)METHYL)PIPERIDIN 1 YL)METHANONE; 3-CHLORO-4-FLUOROPHENYL-(4-FLUORO-4-(((5-METHYLPYRIMIDIN-2-YLMETHYL)AMINO)METHYL)PIPERIDIN-1-YL)METHANONE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; GLUTAMIC ACID; MECP2 PROTEIN, MOUSE; METHYL CPG BINDING PROTEIN 2; PIPERIDINE DERIVATIVE; POTASSIUM; PYRIMIDINE DERIVATIVE; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1 ANTAGONIST; SEROTONIN 1A RECEPTOR;

ACTION POTENTIAL; ANIMAL; APNEA; ARTICLE; BRAIN; BREATHING; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; FEMALE; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; RAPHE NUCLEUS; RETT SYNDROME; SYNAPTIC TRANSMISSION;

APNEA; RETT SYNDROME; SEROTONIN;

ACTION POTENTIALS; ANIMALS; APNEA; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GLUTAMIC ACID; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; PIPERIDINES; POTASSIUM; PYRIMIDINES; RAPHE NUCLEI; RECEPTOR, SEROTONIN, 5-HT1A; RESPIRATION; RETT SYNDROME; SEROTONIN; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; SYNAPTIC TRANSMISSION;

EID: 84890318412     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00889.2013     Document Type: Article

References (36)

1. Abdala AP, Dutschmann M, Bissonnette JM, Paton JF. Correction of respiratory disorders in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 107: 18208-18213, 2010.
2. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188, 1999.
3. Andaku DK, Mercadante MT, Schwartzman JS. Buspirone in Rett syndrome respiratory dysfunction. Brain Dev 27: 437-438, 2005.
4. Assie MB, Bardin L, Auclair AL, Carilla-Durand E, Depoortere R, Koek W, Kleven MS, Colpaert F, Vacher B, Newman-Tancredi A. F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity. Int J Neuropsychopharmacol 13: 1285-1298, 2010.
5. Assie MB, Koek W. Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats. Br J Pharmacol 119: 845-850, 1996.
6. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083-1152, 1999.
7. Bissonnette JM, Knopp SJ. Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice. Pediatr Res 59: 513-518, 2006.
8. Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SB, Guyenet PG, Kipnis J. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484: 105-109, 2012.
9. Dutschmann M, Waki H, Manzke T, Simms AE, Pickering AE, Richter DW, Paton JF. The potency of different serotonergic agonists in counteracting opioid evoked cardiorespiratory disturbances. Philos Trans R Soc Lond B Biol Sci 364: 2611-2623, 2009.
10. Fink KB, Gothert M. 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 59: 360-417, 2007.
11. Gantz SC, Bunzow JR, Williams JT. Spontaneous inhibitory synaptic currents mediated by a G protein-coupled receptor. Neuron 78: 807-812, 2013.
12. Garg SK, Lioy DT, Cheval H, McGann JC, Bissonnette JM, Murtha MJ, Foust KD, Kaspar BK, Bird A, Mandel G. Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. J Neurosci 33: 13612-13620, 2013.
13. Gocho Y, Sakai A, Yanagawa Y, Suzuki H, Saitow F. Electrophysiological and pharmacological properties of GABAergic cells in the dorsal raphe nucleus. J Physiol Sci 63: 147-154, 2013.
14. Gokben S, Ardic UA, Serdaroglu G. Use of buspirone and fluoxetine for breathing problems in Rett syndrome. Pediatr Neurol 46: 192-194, 2012.
15. Hedlund PB, Kelly L, Mazur C, Lovenberg T, Sutcliffe JG, Bonaventure P. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol 487: 125-132, 2004.
16. Katz DM, Dutschmann M, Ramirez JM, Hilaire G. Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir Physiol Neurobiol 168: 101-108, 2009.
17. Lalley PM, Bischoff AM, Richter DW. 5-HT-1A receptor-mediated modulation of medullary expiratory neurones in the cat. J Physiol 476: 117-130, 1994.
18. Lioy DT, Wu WW, Bissonnette JM. Autonomic dysfunction with mutations in the gene that encodes methyl-CpG-binding protein 2: insights into Rett syndrome. Auton Neurosci 161: 55-62, 2011
19. Llado-Pelfort L, Assie MB, Newman-Tancredi A, Artigas F, Celada P. Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors. Br J Pharmacol 160: 1929-1940, 2010.
20. Mannoury la Cour C, El Mestikawy S, Hanoun N, Hamon M, Lanfumey L. Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Mol Pharmacol 70: 1013-1021, 2006.
21. Manzke T, Dutschmann M, Schlaf G, Morschel M, Koch UR, Ponimaskin E, Bidon O, Lalley PM, Richter DW. Serotonin targets inhibitory synapses to induce modulation of network functions. Philos Trans R Soc Lond B Biol Sci 364: 2589-2602, 2009.
22. Manzke T, Niebert M, Koch UR, Caley A, Vogelgesang S, Hulsmann S, Ponimaskin E, Muller U, Smart TG, Harvey RJ, Richter DW. Serotonin receptor 1A-modulated phosphorylation of glycine receptor alpha3 controls breathing in mice. J Clin Invest 120: 4118-4128, 2010.
23. Morikawa H, Manzoni OJ, Crabbe JC, Williams JT. Regulation of central synaptic transmission by 5-HT(1B) auto-and heteroreceptors. Mol Pharmacol 58: 1271-1278, 2000.
24. Mortola JP, Noworaj A. Two-sidearm tracheal cannula for respiratory airflow measurements in small animals. J Appl Physiol 55: 250-253, 1983.
25. Newman-Tancredi A, Martel JC, Assie MB, Buritova J, Lauressergues E, Cosi C, Heusler P, Bruins Slot L, Colpaert FC, Vacher B, Cussac D. Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. Br J Pharmacol 156: 338-353, 2009.
26. Pan ZZ, Colmers WF, Williams JT. 5-HT-mediated synaptic potentials in the dorsal raphe nucleus: interactions with excitatory amino acid and GABA neurotransmission. J Neurophysiol 62: 481-486, 1989.
27. Paton JF. A working heart-brainstem preparation of the mouse. J Neurosci Methods 65: 63-68, 1996.
28. Ramirez JM, Ward CS, Neul JL. Breathing challenges in Rett Syndrome: lessons learned from humans and animal models. Respir Physiol Neurobiol. In press.
29. Richter DW, Manzke T, Wilken B, Ponimaskin E. Serotonin receptors: guardians of stable breathing. Trends Mol Med 9: 542-548, 2003.
30. Sahibzada N, Ferreira M, Wasserman AM, Taveira-DaSilva AM, Gillis RA. Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors. J Pharmacol Exp Ther 292: 704-713, 2000.
31. Southall DP, Kerr AM, Tirosh E, Amos P, Lang MH, Stephenson JB. Hyperventilation in the awake state: potentially treatable component of Rett syndrome. Arch Dis Child 63: 1039-1048, 1988.
32. Stettner GM, Huppke P, Brendel C, Richter DW, Gartner J, Dutschmann M. Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-/y knockout mice. J Physiol 579: 863-876, 2007.
33. Stettner GM, Zanella S, Hilaire G, Dutschmann M. 8-OH-DPAT suppresses spontaneous central apneas in the C57BL/6J mouse strain. Respir Physiol Neurobiol 161: 10-15, 2008.
34. Stettner GM, Zanella S, Huppke P, Gartner J, Hilaire G, Dutschmann M. Spontaneous central apneas occur in the C57BL/6J mouse strain. Respir Physiol Neurobiol 160: 21-27, 2008.
35. Weese-Mayer DE, Lieske SP, Boothby CM, Kenny AS, Bennett HL, Silvestri JM, Ramirez JM. Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr Res 60: 443-449, 2006.
36. Wilken B, Lalley P, Bischoff AM, Christen HJ, Behnke J, Hanefeld F, Richter DW. Treatment of apneustic respiratory disturbance with a serotonin-receptor agonist. J Pediatr 130: 89-94, 1997.